These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28063003)

  • 1. Effect of poly-L-arginine in inhibiting scrapie prion protein of cultured cells.
    Waqas M; Lee HM; Kim J; Telling G; Kim JK; Kim DH; Ryou C
    Mol Cell Biochem; 2017 Apr; 428(1-2):57-66. PubMed ID: 28063003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The suppression of prion propagation using poly-L-lysine by targeting plasminogen that stimulates prion protein conversion.
    Ryou C; Titlow WB; Mays CE; Bae Y; Kim S
    Biomaterials; 2011 Apr; 32(11):3141-9. PubMed ID: 21288569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
    Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
    Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen: A cellular protein cofactor for PrPSc propagation.
    Mays CE; Ryou C
    Prion; 2011; 5(1):22-7. PubMed ID: 21191173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
    Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
    J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The charge structure of helix 1 in the prion protein regulates conversion to pathogenic PrPSc.
    Norstrom EM; Mastrianni JA
    J Virol; 2006 Sep; 80(17):8521-9. PubMed ID: 16912302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation.
    Yadavalli R; Guttmann RP; Seward T; Centers AP; Williamson RA; Telling GC
    J Biol Chem; 2004 May; 279(21):21948-56. PubMed ID: 15026410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activation is stimulated by prion protein and regulated in a copper-dependent manner.
    Ellis V; Daniels M; Misra R; Brown DR
    Biochemistry; 2002 Jun; 41(22):6891-6. PubMed ID: 12033920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiprion properties of prion protein-derived cell-penetrating peptides.
    Löfgren K; Wahlström A; Lundberg P; Langel U; Gräslund A; Bedecs K
    FASEB J; 2008 Jul; 22(7):2177-84. PubMed ID: 18296502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of PrP(Sc) formation in scrapie infected N2a cells by 5,7,8-trimethyl-3,4-dihydro-2H-1,4-benzoxazine derivatives.
    Koukouli F; Paspaltsis I; Salta E; Xanthopoulos K; Koini EN; Calogeropoulou T; Sklaviadis T
    Prion; 2012; 6(5):470-6. PubMed ID: 22918434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen stimulates propagation of protease-resistant prion protein in vitro.
    Mays CE; Ryou C
    FASEB J; 2010 Dec; 24(12):5102-12. PubMed ID: 20732953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfer of scrapie prion infectivity by cell contact in culture.
    Kanu N; Imokawa Y; Drechsel DN; Williamson RA; Birkett CR; Bostock CJ; Brockes JP
    Curr Biol; 2002 Apr; 12(7):523-30. PubMed ID: 11937020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-prion drug mPPIg5 inhibits PrP(C) conversion to PrP(Sc).
    McCarthy JM; Franke M; Resenberger UK; Waldron S; Simpson JC; Tatzelt J; Appelhans D; Rogers MS
    PLoS One; 2013; 8(1):e55282. PubMed ID: 23383136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation.
    Perrier V; Solassol J; Crozet C; Frobert Y; Mourton-Gilles C; Grassi J; Lehmann S
    J Neurochem; 2004 Apr; 89(2):454-63. PubMed ID: 15056288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-surface retention of PrPC by anti-PrP antibody prevents protease-resistant PrP formation.
    Kim CL; Karino A; Ishiguro N; Shinagawa M; Sato M; Horiuchi M
    J Gen Virol; 2004 Nov; 85(Pt 11):3473-3482. PubMed ID: 15483265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a novel, monocationic, small-molecule inhibitor of scrapie prion accumulation in cultured sheep microglia and Rov cells.
    Stanton JB; Schneider DA; Dinkel KD; Balmer BF; Baszler TV; Mathison BA; Boykin DW; Kumar A
    PLoS One; 2012; 7(11):e51173. PubMed ID: 23226483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of prion transmission].
    Sakaguchi S
    Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine cultured cells counteract persistent prion infection by down-regulation of PrPc.
    Aguib Y; Gilch S; Krammer C; Ertmer A; Groschup MH; Schätzl HM
    Mol Cell Neurosci; 2008 May; 38(1):98-109. PubMed ID: 18387818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
    Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
    Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.